用表达靶向 EphA2 CAR 的 mRNA 工程化 NK 细胞增强抗肉瘤免疫
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
50.3分
★★★☆☆
ALL SOURCES
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
CAR-NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer.
过去十年间,嵌合抗原受体(CAR)T细胞疗法彻底改变了肿瘤免疫治疗格局,在儿童和成人复发或难治性血液系统恶性肿瘤的治疗中均展现出显著疗效。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。